Molecular pathways: mitogen-activated protein kinase pathway mutations and drug resistance.
about
p38MAPK and Chemotherapy: We Always Need to Hear Both Sides of the StoryThe Potential of Vitamin D-Regulated Intracellular Signaling Pathways as Targets for Myeloid Leukemia TherapyTumor progression locus 2 (Tpl2) kinase as a novel therapeutic target for cancer: double-sided effects of Tpl2 on cancerDiscrepant alterations in main candidate genes among multiple primary melanomasOncogenic BRAF disrupts thyroid morphogenesis and function via twist expression.Phosphoproteomic Analysis of Cell-Based Resistance to BRAF Inhibitor Therapy in Melanoma.Association of Sp1 and survivin in epithelial ovarian cancer: Sp1 inhibitor and cisplatin, a novel combination for inhibiting epithelial ovarian cancer cell proliferation.miR-634 restores drug sensitivity in resistant ovarian cancer cells by targeting the Ras-MAPK pathway.The Analgesic and Antineuroinflammatory Effect of Baicalein in Cancer-Induced Bone Pain.miR-217 regulates tumor growth and apoptosis by targeting the MAPK signaling pathway in colorectal cancer.The noncoding RNAs SNORD50A and SNORD50B bind K-Ras and are recurrently deleted in human cancer.New RAF kinase inhibitors in cancer therapy.Targeting novel signaling pathways for resistant acute myeloid leukemia.Cytotoxicity of Salvia miltiorrhiza Against Multidrug-Resistant Cancer Cells.The Upregulation of PI3K/Akt and MAP Kinase Pathways is Associated with Resistance of Microtubule-Targeting Drugs in Prostate Cancer.Anti-cancer effects of novel doxorubicin prodrug PDOX in MCF-7 breast cancer cells.In silico identification of novel kinase inhibitors by targeting B-Raf(v660e) from natural products database.A unique set of complex chromosomal abnormalities in an infant with myeloid leukemia associated with Down syndrome.Resistance surveillance in a BRAF mutant melanoma patient on long-term BRAF-inhibitor treatment.Tunicamycin potentiates paclitaxel-induced apoptosis through inhibition of PI3K/AKT and MAPK pathways in breast cancer.JNK/AP-1 activation contributes to tetrandrine resistance in T-cell acute lymphoblastic leukaemia.Single-walled and multi-walled carbon nanotubes induce sequence-specific epigenetic alterations in 16 HBE cells.Altered Cd8+ T lymphocyte Response Triggered by Arginase 1: Implication for Fatigue Intensification during Localized Radiation Therapy in Prostate Cancer Patients
P2860
Q26742078-9C59D576-DA2D-41A7-B70E-E003650C321AQ26799596-C0813685-FC31-464D-B24A-70CE7AC554B7Q27021391-6DB81F07-32A3-49F6-A012-CC18754B5C44Q30578299-C663A4D7-9A95-4B87-9FF3-6332957B6D03Q33558907-8D5118CD-4D28-457C-94FC-37E2B5BCEA83Q35609071-8655F999-F081-430E-B744-AF7BE521CAE5Q36119145-DC5DD3EE-2F40-4C11-9013-5FCEC7D21CC2Q36293209-38E6E663-FA15-4828-8EED-8D67C47A704AQ36327933-100F313C-ED49-4BD4-9FD1-D6BA45BC58C8Q37582210-6BD0F18E-A7A4-4654-9F00-F72ADAEBEFBEQ37664636-B54B3C62-3945-424C-93FF-9BCB995CA27EQ38207082-959E6E4A-EB67-4655-AF81-241C4ED55589Q38297507-B38F4C5B-5A84-4FDE-863B-A87E800BC671Q38768617-F7675662-2F40-4728-A4BE-2F64D98C6BC5Q38914271-F2ADB474-AD1B-4877-8D46-BBFB0E9582C5Q38964767-A7B815A8-93F8-4A36-BFCE-891C990587E2Q39022580-96892520-CF38-4588-B594-0853FBF42553Q41285075-920CA1E3-F017-43D8-85FA-9943BD50CD68Q41859401-541E25C3-9742-4B27-9367-AE1D376C43DEQ47988571-B053EE21-8934-47E8-BE43-C16CFA1924E3Q50949794-5C231F99-B783-4C9C-8528-A9542055ED8BQ55008686-7AF9DCBD-9864-4D43-8667-8D8BEE498D92Q58582886-F4EE0411-7548-442B-A32F-D667572206EB
P2860
Molecular pathways: mitogen-activated protein kinase pathway mutations and drug resistance.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Molecular pathways: mitogen-ac ...... mutations and drug resistance.
@en
type
label
Molecular pathways: mitogen-ac ...... mutations and drug resistance.
@en
prefLabel
Molecular pathways: mitogen-ac ...... mutations and drug resistance.
@en
P1476
Molecular pathways: mitogen-ac ...... mutations and drug resistance.
@en
P2093
Nicholas K Hayward
P304
P356
10.1158/1078-0432.CCR-12-0383
P407
P577
2013-02-13T00:00:00Z